Evidence map›Paper›PMID 33684549›Full record

ArticleHeart rhythm2021

Competing risks in patients with primary prevention implantable cardioverter-defibrillators: Global Electrical Heterogeneity and Clinical Outcomes study.

Jonathan W Waks, Kazi T Haq, Christine Tompkins, Albert J Rogers, Ashkan Ehdaie, Aron Bender, Jessica Minnier, Khidir Dalouk, Stacey Howell, Achille Peiris and 4 more

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Heart rhythm, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03210883 (Global Electrical Heterogeneity and Clinical Outcomes), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03210883 completednot on this map

Global Electrical Heterogeneity and Clinical Outcomes

TypeobservationalSponsorLarisa TereshchenkoRan2017 to 2021Enrolled3,471ConditionsHeart Failure, Implantable Defibrillator User, Ventricular Arrythmia
3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Competing risks of monomorphic vs. non-monomorphic ventricular arrhythmias in primary prevention implantable cardioverter-defibrillator recipients: Global Electrical Heterogeneity and Clinical Outcomes (GEHCO) study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  6. Electrocardiographic risk stratification in patients with a primary prophylactic implantable cardioverter defibrillator: can future arrhythmias correlating with sudden cardiac death be predicted?Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2024
    Article
  7. The spatial ventricular gradient is associated with adverse outcomes in acute pulmonary embolism.Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Jonathan W WaksDepartment of Medicine, Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
Kazi T HaqDepartment of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon.
Christine TompkinsDepartment of Medicine, Cardiovascular Division, University of Colorado, Aurora, Colorado.
Albert J RogersDepartment of Medicine, Cardiovascular Division, University, Palo Alto, California.
Ashkan EhdaieDepartment of Medicine, Cardiovascular Division, Cedars-Sinai Health System, Los Angeles, California.
Aron BenderDepartment of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon.
Jessica MinnierDepartment of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon.
Khidir DaloukDepartment of Medicine, Cardiovascular Division, Portland Health Care System, Portland, Oregon.
Stacey HowellDepartment of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon.
Achille PeirisDepartment of Medicine, Cardiovascular Division, Cedars-Sinai Health System, Los Angeles, California.
Merritt RaittDepartment of Medicine, Cardiovascular Division, Portland Health Care System, Portland, Oregon.
Sanjiv M NarayanDepartment of Medicine, Cardiovascular Division, University, Palo Alto, California.
Sumeet S ChughDepartment of Medicine, Cardiovascular Division, Cedars-Sinai Health System, Los Angeles, California.
Larisa G TereshchenkoDepartment of Medicine, Cardiovascular Division, Oregon Health & Science University, Portland, Oregon. Electronic address: tereshch@ohsu.edu.
Oregon Health & Science University · USSinai Health System · USPalo Alto University · USVA Portland Health Care System · USBeth Israel Deaconess Medical Center · USUniversity of Colorado Anschutz Medical Campus · US

Funding

The Dynamics of Human Atrial FibrillationR01HL083359 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Sanjiv M Narayan · 2008 to 2026
$7.9M
Novel ECG Measures and Risk of Sudden Cardiac DeathR01HL118277 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TERESHCHENKO, LARISA GENNADIEVNA · 2013 to 2016
$1.5M
Novel ECG measures and risk of sudden cardiac deathR56HL118277 · NHLBI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TERESHCHENKO, LARISA GENNADIEVNA · 2018 to 2018
$396k
American Heart Association-American Stroke Association 17GRNT33670428NHLBI NIH HHS R01 HL083359NHLBI NIH HHS R01 HL118277NHLBI NIH HHS R56 HL118277
6 · The paper itself

Abstract

backgroundGlobal electrical heterogeneity (GEH) is associated with sudden cardiac death in the general population. Its utility in patients with systolic heart failure who are candidates for primary prevention (PP) implantable cardioverter-defibrillators (ICDs) is unclear.

objectiveThe purpose of this study was to investigate whether GEH is associated with sustained ventricular tachycardia/ventricular fibrillation leading to appropriate ICD therapies in patients with heart failure and PP ICDs.

methodsWe conducted a multicenter retrospective cohort study. GEH was measured by spatial ventricular gradient (SVG) direction (azimuth and elevation) and magnitude, QRS-T angle, and sum absolute QRST integral on preimplant 12-lead electrocardiograms. Survival analysis using cause-specific hazard functions compared the strength of associations with 2 competing outcomes: sustained ventricular tachycardia/ventricular fibrillation leading to appropriate ICD therapies and all-cause death without appropriate ICD therapies.

resultsWe analyzed 2668 patients (mean age 63 ± 12 years; 624 (23%) female; 78% white; 43% nonischemic cardiomyopathy; left ventricular ejection fraction 28% ± 11% from 6 academic medical centers). After adjustment for demographic, clinical, device, and traditional electrocardiographic characteristics, SVG elevation (hazard ratio [HR] per 1SD 1.14; 95% confidence interval [CI] 1.04-1.25; P = .004), SVG azimuth (HR per 1SD 1.12; 95% CI 1.01-1.24; P = .039), SVG magnitude (HR per 1SD 0.75; 95% CI 0.66-0.85; P < .0001), and QRS-T angle (HR per 1SD 1.21; 95% CI 1.08-1.36; P = .001) were associated with appropriate ICD therapies. Sum absolute QRST integral had different associations in infarct-related cardiomyopathy (HR 1.29; 95% CI 1.04-1.60) and nonischemic cardiomyopathy (HR 0.78; 95% CI 0.62-0.96) (P

conclusionIn patients with PP ICDs, GEH is independently associated with appropriate ICD therapies. The SVG vector points in distinctly different directions in patients with 2 competing outcomes.

Indexed as

Defibrillators, ImplantableDeath, Sudden, CardiacFemaleHeart Failure, SystolicHumansMaleMiddle AgedPrimary PreventionRetrospective StudiesRisk AssessmentRisk FactorsSurvival AnalysisSurvival RateUnited StatesCompeting riskGlobal electrical heterogeneityHeart failureImplantable cardioverter-defibrillatorsVentricular tachycardia/Ventricular fibrillation

Identifiers

PMID33684549
PMCPMC8169548
OpenAlexW3133986926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.